Investigational Drug Information for PF-06882961
✉ Email this page to a colleague
What is the development status for investigational drug PF-06882961?
PF-06882961 is an investigational drug.
There have been 15 clinical trials for PF-06882961.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 6th 2021.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Obesity. The leading clinical trial sponsors are Pfizer and [disabled in preview].
There are four US patents protecting this investigational drug and sixty-two international patents.
Summary for PF-06882961
| US Patents | 4 |
| International Patents | 62 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 11 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 2 (2021-01-06) |
| Vendors | 24 |
Recent Clinical Trials for PF-06882961
| Title | Sponsor | Phase |
|---|---|---|
| STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS | Pfizer | Phase 1 |
| A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus | Pfizer | Phase 1 |
| A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy | Pfizer | Phase 1 |
Clinical Trial Summary for PF-06882961
Top disease conditions for PF-06882961
Top clinical trial sponsors for PF-06882961
US Patents for PF-06882961
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| PF-06882961 | ⤷ Sign Up | GLP-1 receptor agonists and uses thereof | Pfizer Inc. (New York, NY) | ⤷ Sign Up |
| PF-06882961 | ⤷ Sign Up | GLP-1 receptor agonists and uses thereof | Pfizer Inc. (New York, NY) | ⤷ Sign Up |
| PF-06882961 | ⤷ Sign Up | GLP-1R agonists and uses thereof | QILU REGOR THERAPEUTICS INC. (Shanghai, CN) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for PF-06882961
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| PF-06882961 | Argentina | AR110387 | 2036-12-16 | ⤷ Sign Up |
| PF-06882961 | Australia | AU2017374860 | 2036-12-16 | ⤷ Sign Up |
| PF-06882961 | Brazil | BR112019012211 | 2036-12-16 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
